カテゴリー： QYResearch, 世界, 医療/バイオ

世界の転移性膵臓がん治療市場2026：インサイト・予測

【英語タイトル】Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料（QYR20NV12667）・商品コード：QYR20NV12667
・発行会社（調査会社）：QYResearch
・発行日：2020年11月
・ページ数：99
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥405,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥811,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは転移性膵臓がん治療の世界市場について調査・分析した資料です。種類別（化学療法、標的療法、その他）の市場規模、用途別（外分泌、内分泌）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別転移性膵臓がん治療の競争状況、市場シェア
・世界の転移性膵臓がん治療市場：種類別市場規模 2015年-2020年（化学療法、標的療法、その他）
・世界の転移性膵臓がん治療市場：種類別市場規模予測 2021年-2026年（化学療法、標的療法、その他）
・世界の転移性膵臓がん治療市場：用途別市場規模 2015年-2020年（外分泌、内分泌）
・世界の転移性膵臓がん治療市場：用途別市場規模予測 2021年-2026年（外分泌、内分泌）
・北米の転移性膵臓がん治療市場分析：米国、カナダ
・ヨーロッパの転移性膵臓がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの転移性膵臓がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の転移性膵臓がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの転移性膵臓がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Inc
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metastatic pancreatic cancer.

Market Analysis and Insights: Global Metastatic Pancreatic Cancer Treatment Market
The global Metastatic Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Pancreatic Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Pancreatic Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Pancreatic Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Pancreatic Cancer Treatment market.

Global Metastatic Pancreatic Cancer Treatment Scope and Market Size
Metastatic Pancreatic Cancer Treatment market is segmented by Type, and by Pancreatic Cancer. Players, stakeholders, and other participants in the global Metastatic Pancreatic Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Pancreatic Cancer in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Chemotherapy,
Targeted Therapy
Others

Market segment by Pancreatic Cancer, split into
Exocrine
Endocrine

Based on regional and country-level analysis, the Metastatic Pancreatic Cancer Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Metastatic Pancreatic Cancer Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Lilly
Merck
Celgene
BioLineRx
AstraZeneca
Roche
Amgen

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Pancreatic Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy,
1.2.3 Targeted Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer: 2020 VS 2026
1.3.2 Exocrine
1.3.3 Endocrine
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Pancreatic Cancer Treatment Market Perspective (2015-2026)
2.2 Global Metastatic Pancreatic Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Pancreatic Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metastatic Pancreatic Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Pancreatic Cancer Treatment Players by Market Size
3.1.1 Global Top Metastatic Pancreatic Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Metastatic Pancreatic Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Pancreatic Cancer Treatment Revenue
3.4 Global Metastatic Pancreatic Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Pancreatic Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Pancreatic Cancer Treatment Revenue in 2019
3.5 Key Players Metastatic Pancreatic Cancer Treatment Area Served
3.6 Key Players Metastatic Pancreatic Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Pancreatic Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Pancreatic Cancer Treatment Breakdown Data by Type (2015-2026)
4.1 Global Metastatic Pancreatic Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Metastatic Pancreatic Cancer Treatment Breakdown Data by Pancreatic Cancer (2015-2026)
5.1 Global Metastatic Pancreatic Cancer Treatment Historic Market Size by Pancreatic Cancer (2015-2020)
5.2 Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Pancreatic Cancer (2021-2026)

6 North America
6.1 North America Metastatic Pancreatic Cancer Treatment Market Size (2015-2026)
6.2 North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020)
6.3 North America Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020)
6.4 North America Metastatic Pancreatic Cancer Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Metastatic Pancreatic Cancer Treatment Market Size (2015-2026)
7.2 Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020)
7.3 Europe Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020)
7.4 Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Metastatic Pancreatic Cancer Treatment Market Size (2015-2026)
8.2 China Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020)
8.3 China Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020)
8.4 China Metastatic Pancreatic Cancer Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Metastatic Pancreatic Cancer Treatment Market Size (2015-2026)
9.2 Japan Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020)
9.3 Japan Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020)
9.4 Japan Metastatic Pancreatic Cancer Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size (2015-2026)
10.2 Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 Lilly
11.1.1 Lilly Company Details
11.1.2 Lilly Business Overview
11.1.3 Lilly Metastatic Pancreatic Cancer Treatment Introduction
11.1.4 Lilly Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020))
11.1.5 Lilly Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Metastatic Pancreatic Cancer Treatment Introduction
11.2.4 Merck Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.2.5 Merck Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Metastatic Pancreatic Cancer Treatment Introduction
11.3.4 Celgene Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.3.5 Celgene Recent Development
11.4 BioLineRx
11.4.1 BioLineRx Company Details
11.4.2 BioLineRx Business Overview
11.4.3 BioLineRx Metastatic Pancreatic Cancer Treatment Introduction
11.4.4 BioLineRx Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.4.5 BioLineRx Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Metastatic Pancreatic Cancer Treatment Introduction
11.5.4 AstraZeneca Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Metastatic Pancreatic Cancer Treatment Introduction
11.6.4 Roche Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Metastatic Pancreatic Cancer Treatment Introduction
11.7.4 Amgen Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.7.5 Amgen Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Metastatic Pancreatic Cancer Treatment Introduction
11.8.4 Pfizer Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.8.5 Pfizer Recent Development
11.9 Nantkwest, Inc
11.9.1 Nantkwest, Inc Company Details
11.9.2 Nantkwest, Inc Business Overview
11.9.3 Nantkwest, Inc Metastatic Pancreatic Cancer Treatment Introduction
11.9.4 Nantkwest, Inc Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
11.9.5 Nantkwest, Inc Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Pancreatic Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy,
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Others
Table 6. Global Metastatic Pancreatic Cancer Treatment Market Size Growth by Pancreatic Cancer (US$ Million): 2020 VS 2026
Table 7. Global Metastatic Pancreatic Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Metastatic Pancreatic Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2015-2020)
Table 10. Global Metastatic Pancreatic Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2021-2026)
Table 12. Metastatic Pancreatic Cancer Treatment Market Market Trends
Table 13. Metastatic Pancreatic Cancer Treatment Market Drivers
Table 14. Metastatic Pancreatic Cancer Treatment Market Challenges
Table 15. Metastatic Pancreatic Cancer Treatment Market Restraints
Table 16. Global Metastatic Pancreatic Cancer Treatment Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Metastatic Pancreatic Cancer Treatment Market Share by Players (2015-2020)
Table 18. Global Top Metastatic Pancreatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Pancreatic Cancer Treatment as of 2019)
Table 19. Global Metastatic Pancreatic Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Pancreatic Cancer Treatment Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Metastatic Pancreatic Cancer Treatment Market Size Share by Type (2015-2020)
Table 25. Global Metastatic Pancreatic Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 26. Global Metastatic Pancreatic Cancer Treatment Market Size Share by Pancreatic Cancer (2015-2020)
Table 27. Global Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 28. Global Metastatic Pancreatic Cancer Treatment Market Size Share by Pancreatic Cancer (2021-2026)
Table 29. North America Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Metastatic Pancreatic Cancer Treatment Market Share by Type (2015-2020)
Table 31. North America Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 32. North America Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer (2015-2020)
Table 33. North America Metastatic Pancreatic Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Metastatic Pancreatic Cancer Treatment Market Share by Country (2015-2020)
Table 35. Europe Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Metastatic Pancreatic Cancer Treatment Market Share by Type (2015-2020)
Table 37. Europe Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 38. Europe Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer (2015-2020)
Table 39. Europe Metastatic Pancreatic Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Metastatic Pancreatic Cancer Treatment Market Share by Country (2015-2020)
Table 41. China Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 42. China Metastatic Pancreatic Cancer Treatment Market Share by Type (2015-2020)
Table 43. China Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 44. China Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer (2015-2020)
Table 45. China Metastatic Pancreatic Cancer Treatment Market Size by Region (US$ Million) (2015-2020)
Table 46. China Metastatic Pancreatic Cancer Treatment Market Share by Region (2015-2020)
Table 47. Japan Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Metastatic Pancreatic Cancer Treatment Market Share by Type (2015-2020)
Table 49. Japan Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 50. Japan Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer (2015-2020)
Table 51. Japan Metastatic Pancreatic Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Metastatic Pancreatic Cancer Treatment Market Share by Country (2015-2020)
Table 53. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Share by Type (2015-2020)
Table 55. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Pancreatic Cancer (2015-2020) (US$ Million)
Table 56. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer (2015-2020)
Table 57. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Share by Country (2015-2020)
Table 59. Lilly Company Details
Table 60. Lilly Business Overview
Table 61. Lilly Product
Table 62. Lilly Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 63. Lilly Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Product
Table 67. Merck Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 68. Merck Recent Development
Table 69. Celgene Company Details
Table 70. Celgene Business Overview
Table 71. Celgene Product
Table 72. Celgene Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 73. Celgene Recent Development
Table 74. BioLineRx Company Details
Table 75. BioLineRx Business Overview
Table 76. BioLineRx Product
Table 77. BioLineRx Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 78. BioLineRx Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Product
Table 82. AstraZeneca Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 88. Roche Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Product
Table 92. Amgen Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 93. Amgen Recent Development
Table 94. Pfizer Business Overview
Table 95. Pfizer Product
Table 96. Pfizer Company Details
Table 97. Pfizer Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Nantkwest, Inc Company Details
Table 100. Nantkwest, Inc Business Overview
Table 101. Nantkwest, Inc Product
Table 102. Nantkwest, Inc Revenue in Metastatic Pancreatic Cancer Treatment Business (2015-2020) (US$ Million)
Table 103. Nantkwest, Inc Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Pancreatic Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy, Features
Figure 3. Targeted Therapy Features
Figure 4. Others Features
Figure 5. Global Metastatic Pancreatic Cancer Treatment Market Share by Pancreatic Cancer: 2020 VS 2026
Figure 6. Exocrine Case Studies
Figure 7. Endocrine Case Studies
Figure 8. Metastatic Pancreatic Cancer Treatment Report Years Considered
Figure 9. Global Metastatic Pancreatic Cancer Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Metastatic Pancreatic Cancer Treatment Market Share by Regions (2021-2026)
Figure 12. Global Metastatic Pancreatic Cancer Treatment Market Share by Players in 2019
Figure 13. Global Top Metastatic Pancreatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Pancreatic Cancer Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Metastatic Pancreatic Cancer Treatment Revenue in 2019
Figure 15. North America Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Metastatic Pancreatic Cancer Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Lilly Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 43. Merck Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 44. Celgene Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 45. BioLineRx Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 46. AstraZeneca Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 47. Roche Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 48. Amgen Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 49. Pfizer Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 50. Nantkwest, Inc Revenue Growth Rate in Metastatic Pancreatic Cancer Treatment Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed


【掲載企業】

Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Inc

★調査レポート[世界の転移性膵臓がん治療市場2026：インサイト・予測] (コード：QYR20NV12667)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の転移性膵臓がん治療市場2026：インサイト・予測]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 局所進行膵がん（LAPC）治療薬の世界市場：インサイト・疫学・市場予測
    DELV20JU070 / DelveInsight / 2020年6月 / ...DelveInsight's "Locally Advanced Pancreatic Cancer (LAPC) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Locally Advanced Pancreatic Cancer (LAPC), historical and forecasted epidemiology as well as the Locally Advanced Pancreatic Cancer (LAPC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Locally Advanced Pancreatic Cancer (LAPC) market report provides current treatment practices, emerging drugs, Locally Advanced Pancreatic Cancer (LAPC) market share of the individual therapies, current and forecasted Locally Advanced Pancreatic Cancer (LAPC) market Size from 2017 to 2030 segmented by seven major markets. The Report...
  • 転移性去勢感受性前立腺がん（mCSPC）治療薬の世界市場：インサイト・疫学・市場予測
    DELV20JU078 / DelveInsight / 2020年6月 / ...DelveInsight's "Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Metastatic Castration-Sensitive Prostate Cancer (mCSPC), historical and forecasted epidemiology as well as the Metastatic Castration-Sensitive Prostate Cancer (mCSPC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Castration-Sensitive Prostate Cancer (mCSPC) market report provides current treatment practices, emerging drugs, Metastatic Castration-Sensitive Prostate Cancer (mCSPC) market share of the individual therapies, current and forecasted Metastatic Castration-Sensitive Prostate Cancer (mCSPC) market Size from 2017 to 2030 segmented by seven major markets. The Report...
  • 転移性トリプルネガティブ乳がん（mTNBC）治療薬の世界市場：インサイト・疫学・市場予測
    DELV20JU079 / DelveInsight / 2020年6月 / ...DelveInsight's "Metastatic triple-negative breast cancer (mTNBC) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Metastatic triple-negative breast cancer (mTNBC), historical and forecasted epidemiology as well as the Metastatic triple-negative breast cancer (mTNBC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic triple-negative breast cancer (mTNBC) market report provides current treatment practices, emerging drugs, Metastatic triple-negative breast cancer (mTNBC) market share of the individual therapies, current and forecasted Metastatic triple-negative breast cancer (mTNBC) market Size from 2017 to 2030 segmented by seven major markets. The Report...
  • 去勢敏感性前立腺がん（CSPC）治療薬の世界市場：インサイト・疫学・市場予測
    DELV20JU152 / DelveInsight / 2020年6月 / ...DelveInsight’s ‘Castrate-Sensitive Prostate Cancer (CSPC) Market Insights, Epidemiology and Market Forecast - 2030’ report delivers an in-depth understanding of the CSPC, historical and forecasted epidemiology as well as the CSPC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The CSPC market report provides current treatment practices, emerging drugs, CSPC market share of the individual therapies, current and forecasted CSPC market size from 2017 to 2030 segmented by seven major markets. The Report also covers current CSPC treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities...
  • 世界のファーマコビジランス市場2026：インサイト・予測
    QYR20NV04258 / QYResearch / 2020年11月 / 本調査レポートはファーマコビジランスの世界市場について調査・分析した資料です。種類別（化学療法、契約アウトソーシング）の市場規模、用途別（製薬およびバイオテクノロジー企業、委託研究機関（CRO）、ビジネスプロセスアウトソーシング（BPO）企業、その他）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ファーマコビジランスの競争状況、市場シェア ・世界のファーマコビジランス市場：種類別市場規模 2015年-2020年（化学療法、契約アウトソーシング） ・世界のファーマコビジランス市場：種類別市場規模予測 2021年-2026年（化学療法、契約アウトソーシング） ・世界のファーマコビジランス市場：用途別市場規模 2015年-2020年（製薬およびバイオテクノロジー企業、委託研究機関（CRO）、ビジネスプロセスアウトソーシング（BPO）企業、その他）...Market Analysis and Insights: Global Pharmacovigilance Market The global Pharmacovigilance market size is projected to reach US$ 4521.3 million by 2026, from US$ 4159.2 million in 2020, at a CAGR of 8.1%% during 2021-2026. Global Pharmacovigilance Scope and Market Size Pharmacovigilance market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The...
  • 転移性骨痛治療薬の世界市場：インサイト・疫学・市場予測
    DELV20JU077 / DelveInsight / 2020年6月 / ...DelveInsight's "Metastatic Bone Pain - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Metastatic Bone Pain , historical and forecasted epidemiology as well as the Metastatic Bone Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Bone Pain market report provides current treatment practices, emerging drugs, Metastatic Bone Pain market share of the individual therapies, current and forecasted Metastatic Bone Pain market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Metastatic Bone Pain treatment practice/algorithm, market drivers, market...
  • 世界の記憶インプラント市場2026：インサイト・予測
    QYR20NV12644 / QYResearch / 2020年11月 / 本調査レポートは記憶インプラントの世界市場について調査・分析した資料です。種類別（定位移植、電気生理学的マッピング、その他技術）の市場規模、用途別（臨床研究機関、医療サービスプロバイダー、その他）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別記憶インプラントの競争状況、市場シェア ・世界の記憶インプラント市場：種類別市場規模 2015年-2020年（定位移植、電気生理学的マッピング、その他技術） ・世界の記憶インプラント市場：種類別市場規模予測 2021年-2026年（定位移植、電気生理学的マッピング、その他技術） ・世界の記憶インプラント市場：用途別市場規模 2015年-2020年（臨床研究機関、医療サービスプロバイダー、その他）...Memory implants are useful in controlling the voluntary actions of the brain in people who suffer from brain damage due to stroke, Alzheimer’s, and disruption of neural network. The memory implant market plays a key role in the overall neurological research industry. A number of researchers are working on developing remarkable memory implants that can perform various functions including pain management and controlling of heart beats, and controlling symptoms of Parkinson’s disease, sleep apnea, and various neurology diseases. Though, advanced technology in the healthcare industry might have succeeded in bringing down the mortality rate, there is still dearth of treatments...
  • 世界の抗糖尿病治療薬市場2026：インサイト・予測
    QYR20NV10866 / QYResearch / 2020年11月 / 本調査レポートは抗糖尿病治療薬の世界市場について調査・分析した資料です。種類別（ビグアニド、スルホニル尿素、メグリチニド、チアゾリジンジオン、ジペプチジルペプチダーゼIV阻害剤、α-グルコシダーゼ阻害剤）の市場規模、用途別（I型糖尿病、II型糖尿病、その他）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗糖尿病治療薬の競争状況、市場シェア ・世界の抗糖尿病治療薬市場：種類別市場規模 2015年-2020年（ビグアニド、スルホニル尿素、メグリチニド、チアゾリジンジオン、ジペプチジルペプチダーゼIV阻害剤、α-グルコシダーゼ阻害剤） ・世界の抗糖尿病治療薬市場：種類別市場規模予測 2021年-2026年（ビグアニド、スルホニル尿素、メグリチニド、チアゾリジンジオン、ジペプチジルペプチダーゼIV阻害剤、α-グルコシダーゼ阻害剤） ・世界の抗糖尿病治療薬市場：用途別市場規模 2015年-2020年（I型糖尿病、II型糖尿病、その他）...The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages...
  • 世界の肺/呼吸器ドラッグデリバリー市場2026：インサイト・予測
    QYR20NV04417 / QYResearch / 2020年11月 / 本調査レポートは肺/呼吸器ドラッグデリバリーの世界市場について調査・分析した資料です。種類別（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤）の市場規模、用途別（病院、在宅ケア）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺/呼吸器ドラッグデリバリーの競争状況、市場シェア ・世界の肺/呼吸器ドラッグデリバリー市場：種類別市場規模 2015年-2020年（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤） ・世界の肺/呼吸器ドラッグデリバリー市場：種類別市場規模予測 2021年-2026年（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤） ・世界の肺/呼吸器ドラッグデリバリー市場：用途別市場規模 2015年-2020年（病院、在宅ケア）...Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026. Global Pulmonary/ Respiratory Drug Delivery Scope and Market Size Pulmonary/ Respiratory Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary/ Respiratory Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by...
  • 世界のヒアルロン酸（HA）原料市場2026：インサイト・予測
    QYR20NV12261 / QYResearch / 2020年11月 / 本調査レポートはヒアルロン酸（HA）原料の世界市場について調査・分析した資料です。種類別（動物組織由来、合成、その他）の市場規模、用途別（眼科、整形外科、皮膚科、ドラッグデリバリー、医療機器コーティング、外科的付着防止、生体材料・インプラント、細胞・組織保存）の市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒアルロン酸（HA）原料の競争状況、市場シェア ・世界のヒアルロン酸（HA）原料市場：種類別市場規模 2015年-2020年（動物組織由来、合成、その他） ・世界のヒアルロン酸（HA）原料市場：種類別市場規模予測 2021年-2026年（動物組織由来、合成、その他） ・世界のヒアルロン酸（HA）原料市場：用途別市場規模 2015年-2020年（眼科、整形外科、皮膚科、ドラッグデリバリー、医療機器コーティング、外科的付着防止、生体材料・インプラント、細胞・組織保存）...Raw materials used in hyaluronic acid production from many resouces. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period. Market Analysis and Insights: Global Hyaluronic Acid (HA) Raw Material Market The global Hyaluronic Acid (HA) Raw Material market size is projected to reach US$ 4669.5 million by 2026, from US$ 4485.3 million in 2020, at a CAGR of 3.8%% during 2021-2026. Global Hyaluronic Acid (HA) Raw Material Scope and Market...

    • ◆H&Iグローバルリサーチのお客様（例）◆